Nora Franceschini1, Natalia A Gouskova2, Alex P Reiner3, Andrew Bostom4, Barbara V Howard5, Mary Pettinger6, Jason G Umans5, M Alan Brookhart7, Wolfgang C Winkelmayer8, Charles B Eaton4, Gerardo Heiss7, Jason P Fine2. 1. Departments of Epidemiology and noraf@unc.edu. 2. Biostatistics, University of North Carolina, Chapel Hill, North Carolina; 3. Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington; 4. Department of Family Medicine and Epidemiology, Alpert Medical School of Brown University, Providence, Rhode Island; 5. MedStar Health Research Institute, Hyattsville, Maryland; Center for Clinical and Translational Sciences and Department of Medicine, Georgetown-Howard Universities, Washington, DC; 6. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; and. 7. Departments of Epidemiology and. 8. Section of Nephrology, Baylor College of Medicine, Houston, Texas.
Abstract
BACKGROUND AND OBJECTIVES: Body mass index and waist circumference associate with adverse health outcomes, including CKD. Studies of the association of body mass index and ESRD have been inconsistent; these adiposity measures have not been previously assessed together for ESRD risk or among postmenopausal women. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: This was prospective cohort study of 20,117 postmenopausal women enrolled in the multiethnic cohort of the Women's Health Initiative. Body mass index and waist circumference were obtained at baseline, incident ESRD was obtained from the US Renal Data System, and all-cause death was obtained from surveillance data. A competing-risk framework was used to account for the effect of mortality before ESRD while adjusting for significant predictors and baseline kidney function. Associations of adiposity with mortality were also studied. RESULTS: Events included 212 patients with incident ESRD and 3104 deaths for a mean follow-up of 11.6 years. Increased waist circumference and body mass index were associated with 2.59- (95% confidence interval, 1.89 to 3.53) and 1.97-fold (95% confidence interval, 1.30 to 2.98) higher hazards of ESRD as well as 1.42- (95% confidence interval, 1.32 to 1.53) and 1.21-fold (95% confidence interval, 1.11 to 1.33) higher hazards of death, respectively, compared with the lower categories in adjusted analyses. The associations of waist circumference with ESRD varied by baseline renal function (P for interaction=0.01) and were significant only among women without baseline eGFR-defined CKD (hazard ratio, 1.93; 95% confidence interval, 1.23 to 3.03). CONCLUSIONS: Central obesity was associated with an increased risk of ESRD in postmenopausal women, even among women with normal body mass index but not among women with reduced baseline kidney function, and an increased risk of death. Body mass index was associated with ESRD, and the association is likely mediated through hypertension and diabetes.
BACKGROUND AND OBJECTIVES: Body mass index and waist circumference associate with adverse health outcomes, including CKD. Studies of the association of body mass index and ESRD have been inconsistent; these adiposity measures have not been previously assessed together for ESRD risk or among postmenopausal women. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: This was prospective cohort study of 20,117 postmenopausal women enrolled in the multiethnic cohort of the Women's Health Initiative. Body mass index and waist circumference were obtained at baseline, incident ESRD was obtained from the US Renal Data System, and all-cause death was obtained from surveillance data. A competing-risk framework was used to account for the effect of mortality before ESRD while adjusting for significant predictors and baseline kidney function. Associations of adiposity with mortality were also studied. RESULTS: Events included 212 patients with incident ESRD and 3104 deaths for a mean follow-up of 11.6 years. Increased waist circumference and body mass index were associated with 2.59- (95% confidence interval, 1.89 to 3.53) and 1.97-fold (95% confidence interval, 1.30 to 2.98) higher hazards of ESRD as well as 1.42- (95% confidence interval, 1.32 to 1.53) and 1.21-fold (95% confidence interval, 1.11 to 1.33) higher hazards of death, respectively, compared with the lower categories in adjusted analyses. The associations of waist circumference with ESRD varied by baseline renal function (P for interaction=0.01) and were significant only among women without baseline eGFR-defined CKD (hazard ratio, 1.93; 95% confidence interval, 1.23 to 3.03). CONCLUSIONS:Central obesity was associated with an increased risk of ESRD in postmenopausal women, even among women with normal body mass index but not among women with reduced baseline kidney function, and an increased risk of death. Body mass index was associated with ESRD, and the association is likely mediated through hypertension and diabetes.
Authors: J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty Journal: Ann Epidemiol Date: 2003-10 Impact factor: 3.797
Authors: Friedrich K Port; Valarie B Ashby; Rajnish K Dhingra; Erik C Roys; Robert A Wolfe Journal: J Am Soc Nephrol Date: 2002-04 Impact factor: 10.121
Authors: A R Folsom; L H Kushi; K E Anderson; P J Mink; J E Olson; C P Hong; T A Sellers; D Lazovich; R J Prineas Journal: Arch Intern Med Date: 2000-07-24
Authors: Eric L Knight; Jacobien C Verhave; Donna Spiegelman; Hans L Hillege; Dick de Zeeuw; Gary C Curhan; Paul E de Jong Journal: Kidney Int Date: 2004-04 Impact factor: 10.612
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy Journal: JAMA Date: 2004-02-18 Impact factor: 56.272
Authors: Holly Kramer; Orlando M Gutiérrez; Suzanne E Judd; Paul Muntner; David G Warnock; Rikki M Tanner; Bhupesh Panwar; David A Shoham; William McClellan Journal: Am J Kidney Dis Date: 2015-07-15 Impact factor: 8.860
Authors: Magdalena Madero; Ronit Katz; Rachel Murphy; Anne Newman; Kushang Patel; Joachim Ix; Carmen Peralta; Suzanne Satterfield; Linda Fried; Michael Shlipak; Mark Sarnak Journal: Clin J Am Soc Nephrol Date: 2017-05-18 Impact factor: 8.237
Authors: Nora Franceschini; Jeffrey B Kopp; Ana Barac; Lisa W Martin; Yun Li; Huijun Qian; Alex P Reiner; Martin Pollak; Robert B Wallace; Wayne D Rosamond; Cheryl A Winkler Journal: JAMA Cardiol Date: 2018-08-01 Impact factor: 14.676
Authors: Emily de S Ferreira; Luciana S da Silva; Glauce D da Costa; Tiago R Moreira; Luíza D Borges; Rosângela M M Cotta Journal: J Nutr Sci Date: 2020-09-30